These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 766340)

  • 21. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide.
    Girling DJ
    Tubercle; 1978 Mar; 59(1):13-32. PubMed ID: 345572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Report on experiences with ethambutol.
    Böszörményi M
    Antibiot Chemother; 1970; 16():292-3. PubMed ID: 5535615
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse reactions to short-course regimens containing streptomycin, isoniazid, pyrazinamide and rifampicin in Hong Kong.
    Tubercle; 1976 Jun; 57(2):81-95. PubMed ID: 134476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retreatment of tuberculosis patients in the city of Porto Alegre, Brazil: outcomes.
    Picon PD; Rizzon CF; Bassanesi SL; Silva LC; Della Giustina Mde L
    J Bras Pneumol; 2011; 37(4):504-11. PubMed ID: 21881741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis.
    Lancet; 1981 Jan; 1(8213):171-4. PubMed ID: 6109855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
    Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical study.
    Zierski M; Bek E
    Tubercle; 1980 Mar; 61(1):41-9. PubMed ID: 6989067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis.
    Babu Swai O; Aluoch JA; Githui WA; Thiong'o R; Edwards EA; Darbyshire JH; Nunn AJ
    Tubercle; 1988 Mar; 69(1):5-14. PubMed ID: 3051607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.
    Am Rev Respir Dis; 1979 Apr; 119(4):579-85. PubMed ID: 375787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 34. Ethambutol plus isoniazid for the treatment of pulmonary tuberculosis--a controlled trial of our regimens.
    Tubercle; 1981 Mar; 62(1):13-29. PubMed ID: 7022973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
    Reves R; Heilig CM; Tapy JM; Bozeman L; Kyle RP; Hamilton CD; Bock N; Narita M; Wing D; Hershfield E; Goldberg SV;
    Int J Tuberc Lung Dis; 2014 May; 18(5):571-80. PubMed ID: 24903795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.
    Jindani A; Nunn AJ; Enarson DA
    Lancet; 2004 Oct 2-8; 364(9441):1244-51. PubMed ID: 15464185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
    Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
    Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
    Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a non-rifampicin continuation phase (6HE) following thrice-weekly intensive phase for the treatment of new sputum positive pulmonary tuberculosis.
    Indian J Tuberc; 2007 Apr; 54(2):84-90. PubMed ID: 17575680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR; Lind A; Rist N
    Bull Int Union Tuberc; 1969 Aug; 42():7-57. PubMed ID: 5004884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.